BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 32375658)

  • 21. Efficacy and side effects of praziquantel treatment against Schistosoma haematobium infection among primary school children in Zimbabwe.
    Midzi N; Sangweme D; Zinyowera S; Mapingure MP; Brouwer KC; Kumar N; Mutapi F; Woelk G; Mduluza T
    Trans R Soc Trop Med Hyg; 2008 Aug; 102(8):759-66. PubMed ID: 18486169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and efficacy of praziquantel syrup (Epiquantel®) against Schistosoma haematobium and Schistosoma mansoni in preschool-aged children in Niger.
    Garba A; Lamine MS; Djibo A; Tahirou A; Aouami MA; Alfari A; Phillips AE; Fenwick A; Utzinger J
    Acta Trop; 2013 Nov; 128(2):318-25. PubMed ID: 23237719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of mefloquine, artesunate, mefloquine-artesunate, and praziquantel against Schistosoma haematobium: randomized, exploratory open-label trial.
    Keiser J; N'Guessan NA; Adoubryn KD; Silué KD; Vounatsou P; Hatz C; Utzinger J; N'Goran EK
    Clin Infect Dis; 2010 May; 50(9):1205-13. PubMed ID: 20350194
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predicted impact of mass drug administration on the development of protective immunity against Schistosoma haematobium.
    Mitchell KM; Mutapi F; Mduluza T; Midzi N; Savill NJ; Woolhouse ME
    PLoS Negl Trop Dis; 2014; 8(7):e3059. PubMed ID: 25079601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of Praziquantel against Schistosoma haematobium in Dulshatalo village, western Ethiopia.
    Mekonnen A; Legesse M; Belay M; Tadesse K; Torben W; Teklemariam Z; Erko B
    BMC Res Notes; 2013 Sep; 6():392. PubMed ID: 24073761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of MIP-1alpha/CCL3 with praziquantel treatment in Schistosoma haematobium and HIV-1 co-infected individuals in a rural community in Zimbabwe.
    Zinyama-Gutsire R; Gomo E; Kallestrup P; Erikstrup C; Ullum H; Butterworth AE; Munyati S; Mduluza T
    BMC Infect Dis; 2009 Oct; 9():174. PubMed ID: 19852800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of ascending doses of praziquantel against Schistosoma haematobium infection in preschool-aged and school-aged children: a single-blind randomised controlled trial.
    Coulibaly JT; Panic G; Yapi RB; Kovač J; Barda B; N'Gbesso YK; Hattendorf J; Keiser J
    BMC Med; 2018 Jun; 16(1):81. PubMed ID: 29855373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of China-made praziquantel for treatment of Schistosomiasis haematobium in Africa: A randomized controlled trial.
    Wang XY; He J; Juma S; Kabole F; Guo JG; Dai JR; Li W; Yang K
    PLoS Negl Trop Dis; 2019 Apr; 13(4):e0007238. PubMed ID: 30969960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review.
    King CH; Olbrych SK; Soon M; Singer ME; Carter J; Colley DG
    PLoS Negl Trop Dis; 2011 Sep; 5(9):e1321. PubMed ID: 21949893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure of standard treatment with praziquantel in two returned travelers with Schistosoma haematobium infection.
    Alonso D; Muñoz J; Gascón J; Valls ME; Corachan M
    Am J Trop Med Hyg; 2006 Feb; 74(2):342-4. PubMed ID: 16474094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Côte d'Ivoire.
    N'Goran EK; Gnaka HN; Tanner M; Utzinger J
    Ann Trop Med Parasitol; 2003 Jan; 97(1):37-51. PubMed ID: 12662421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa.
    Saathoff E; Olsen A; Magnussen P; Kvalsvig JD; Becker W; Appleton CC
    BMC Infect Dis; 2004 Oct; 4():40. PubMed ID: 15471549
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diagnosis and treatment of an imported case of schistosomiasis haematobium].
    Yan-Rong L; Han-Guo X; Zhu-Yun C; Li-Zhen X; Rong-Yan Z
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2017 Jan; 29(1):108-110. PubMed ID: 29469403
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of low doses of praziquantel for Schistosoma mansoni and S. haematobium.
    Taylor P; Murare HM; Manomano K
    J Trop Med Hyg; 1988 Feb; 91(1):13-7. PubMed ID: 3126306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Schistosoma haematobium infections among schoolchildren in central Sudan one year after treatment with praziquantel.
    Ahmed AM; Abbas H; Mansour FA; Gasim GI; Adam I
    Parasit Vectors; 2012 Jun; 5():108. PubMed ID: 22676052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detectable urogenital schistosome DNA and cervical abnormalities 6 months after single-dose praziquantel in women with Schistosoma haematobium infection.
    Downs JA; Kabangila R; Verweij JJ; Jaka H; Peck RN; Kalluvya SE; Changalucha JM; Johnson WD; van Lieshout L; Fitzgerald DW
    Trop Med Int Health; 2013 Sep; 18(9):1090-1096. PubMed ID: 23937701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of single-dose 40 mg/kg oral praziquantel in the treatment of schistosomiasis in preschool-age versus school-age children: An individual participant data meta-analysis.
    Olliaro PL; Coulibaly JT; Garba A; Halleux C; Keiser J; King CH; Mutapi F; N'Goran EK; Raso G; Scherrer AU; Sousa-Figueiredo JC; Stete K; Utzinger J; Vaillant MT
    PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008277. PubMed ID: 32569275
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomized comparison of low-dose versus standard-dose praziquantel therapy in treatment of urinary tract morbidity due to Schistosoma haema tobium infection.
    King CH; Muchiri EM; Mungai P; Ouma JH; Kadzo H; Magak P; Koech DK
    Am J Trop Med Hyg; 2002 Jun; 66(6):725-30. PubMed ID: 12224581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endemic status of urogenital schistosomiasis and the efficacy of a single-dose praziquantel treatment in unmapped rural farming communities in Oyo East Local Government Area, Oyo State, Nigeria.
    Odaibo AB; Komolafe AK; Olajumoke TO; Diyan KD; Aluko DA; Alagbe OA; Ajagbe OA; Olarinloye DB
    PLoS Negl Trop Dis; 2024 Apr; 18(4):e0012101. PubMed ID: 38620032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High Efficacy of Praziquantel in
    Houmsou RS; Wama BE; Agere H; Uniga JA; Amuta EU; Kela SL
    Sultan Qaboos Univ Med J; 2018 Aug; 18(3):e304-e310. PubMed ID: 30607270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.